Illness Expectations Tied to Asthma Outcomes
By Lori Solomon HealthDay Reporter

WEDNESDAY, July 16, 2025 -- Illness expectations may be meaningfully associated with asthma symptoms and respiratory function, according to a study published online in the June issue of Health Expectations.
Eleonora Volpato, Ph.D., from the Università Cattolica del Sacro Cuore in Milan, and colleagues empirically evaluated the impact of illness expectations on asthma symptoms and respiratory function in a longitudinal cohort study. The analysis included 310 individuals 18 years or older diagnosed with asthma who were followed for a six-month period.
The researchers found that people with more negative explicit illness expectations about their asthma reported worse symptoms over time (β = −0.50). For implicit illness expectations, the association was not statistically significant (β = −0.014). There was an association between explicit illness expectations about symptom progression and changes in lung function, with more negative expectations predicting greater declines in respiratory performance (β = 0.51).
"These insights suggest that fostering positive expectations in patients could be a useful strategy in asthma care, potentially improving treatment adherence and symptom control," the authors write. "Moreover, in the routine management of asthma, it might be relevant to use tools such as those we used in the study to make brief assessments of illness expectations during clinical consultations."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-17 06:00
Read more

- Drinking Coffee May Help You Live Longer — But Skip the Extra Sugar
- VR Might Aid Stroke Recovery
- Studies Address Muscle Loss Caused By GLP-1 Drugs, such as Ozempic and Zepbound
- Higher Dose of Wegovy Provided Average Weight Loss of 21% in People with Obesity With a Third Achieving 25% or More
- NIH to Fund $10M in Long-Term Health Studies After Ohio Train Disaster
- FDA Approves Ekterly (sebetralstat) the First and Only Oral On-demand Treatment for Hereditary Angioedema (HAE)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions